The pathological effect of the Bacillus thuringiensis Cry δ-endotoxins on susceptible insect larvae had extensive damage on the midgut epithelial cells. In this study, an ex vivo assay was devised for assessing the insecticidal potency of the cloned Cry4B mosquito-larvicidal protein that is expressed in Escherichia coli. Determination of toxicity was carried out by using a cell viability assay on the midguts that were dissected from 5-day old Aedes aegypti mosquito larvae. After incubation with the toxin proteins, the number of viable epithelial cells was determined photometrically by monitoring the quantity of the bioreduced formazan product at 490 nm. The results showed that the 65-kDa trypsin-activated Cry4B toxin exhibited toxic potency ca. 3.5 times higher than the 130-kDa Cry4B protoxin. However, the trypsin-treated products of the non-bioactive Cry4B mutant (R158A) and the lepidopteran-specific Cry1Aa toxin displayed relatively no ex vivo activity on the mosquito-larval midguts. The ex vivo cytotoxicity studies presented here confirms data that was obtained in bioassays.
Introduction
During sporulation, Bacillus thuringiensis (Bt) synthesizes cytoplasmic crystalline inclusions, which contain one or more proteins of varying molecular mass (Aronson et al., 1986 ).
These crystal proteins, which have been classified as Cry and Cyt δ-endotoxins, are specifically toxic to the larvae of insect crop pests and disease vectors (Hofte and Whiteley, 1989; Crickmore et al., 1998; Schnepf et al., 1998) . For instance, the 130-kDa Cry4B δ-endotoxin, one of the four major insecticidal proteins that are produced by Bt subsp. israelensis (Bti), is highly toxic to mosquito larvae, including the Aedes and Anopheles species (Hofte and Whiteley, 1989; Angsuthanasombat et al., 1992; Schnepf et al., 1998) .
In the Bt inclusion bodies, the δ-endotoxins exist as inactive protoxins that are dependent on the larval midgut environment for solubilization and proteolytic activation. When ingested by susceptible insect larvae, the protein inclusions are solubilized and the protoxins activated by the alkaline pH and proteases of the larval midgut. The activated toxins first recognize and bind to specific receptors that line the microvillus surface of midgut epithelial cells, and then insert into the plasma membrane of the epithelial cells, causing them to swell and lyse. The larvae then stop feeding and eventually die (Aronson et al, 1986; Knowles, 1994) .
The cytolytic activity of a number of the Cry toxins has been demonstrated in vitro using a wide range of lepidopteran and dipteran cell lines (Knowles and Ellar, 1987; Thomas and Ellar, 1993) . Our earlier work revealed that the in vitro cytotoxicity of the cloned Cry4B toxin to mosquito cell lines is not entirely consistent with its toxicity in vivo (Angsuthanasombat et al., 1993) . Poor correlations, observed between in vivo and in vitro assays of the Cry2Aa toxin, have been reported (Nicholls et al., 1989) . Even considering these observations, the insect cell line assay might not be a good model system for studying toxin mechanism in vitro since the cell lines that were used did not originate from the midgut epithelial cell targets of these Bt toxins (Hink, 1972) . Presently, no insect midgut epithelial cell line has been successfully cultured in vitro. It would therefore be interesting to employ the isolated larval midguts for investigating this *To whom correspondence should be addressed. Tel: 662-441-9003 ext. 1237; Fax: 662-441-9906 E-mail: stcas@mahidol.ac.th underlying toxicity mechanism. In this report, we describe a microscale ex vivo toxicity assay for demonstration of the cytolytic activity of the cloned Cry4B toxin on isolated midguts from Aedes aegypti mosquito larvae.
Materials and Methods
Toxin expression, inclusion solubilization, and proteolytic activation The cloned Cry4B toxin (Angsuthanasombat et al., 1987) , its non-toxic R158A mutant (Sramala et al., 2001) , and the cloned Cry1Aa toxin (a generous gift of Dr. J-L Schwartz, National Research Council of Canada) were over-expressed in E. coli as inclusion bodies upon IPTG (isopropyl-β-D-thiogalactopyranoside) induction at 37 o C. After disruption in a French Press Cell, protoxin inclusions in the crude lysates were obtained by centrifugation, as described earlier (Uawithya et al., 1998) . Protein concentrations were determined by using a dye-binding method (BioRad, Hercules, USA), with bovine serum albumin (Sigma, St. Louis, USA) as a standard. Protoxin inclusions (3-5 mg ml −1 ) were solubilized in 50 mM Na 2 CO 3 , pH 10.0 at 37 o C for 60 min. The solubilized protoxins were digested with trypsin (N-tosyl-Lphenylalanine chloromethyl ketone treated, Sigma) at a toxin:enzyme ratio of 20 : 1 (w/w) for 12 h, and were analyzed by 12.5% (w/v) SDS polyacrylamide gel electrophoresis as described previously (Uawithya et al., 1998) .
Larval midgut preparation Aedes aegypti and Culex quinquefasciatus mosquito eggs that were obtained from the mosquito-rearing facility (Institute of Molecular Biology and Genetics, Mahidol University) were hatched in a plastic container (22 × 30 × 10 cm deep) with 500 ml of fresh tap water that was supplemented with 2 pieces of fish diet (0.12 g per piece). After a 24 h incubation, approximately 200 larvae were placed into a new container with 1,000 ml of water and 3 pieces of diet pellets. Each day, the 1,000 ml of water and 3 pieces of diet were replaced, and rearing was carried out at 30 o C. Before being used for the midgut preparation, 4-d old healthy larvae were selected for a fast of 24 h in 1,500 ml of fresh water.
The 5-d old larvae were then chilled in an ice-cold dissecting buffer (5 mM KCl, 0.5 mM MgSO 4 , 100 mM NaCl, 20 mM NaHCO 3 , 5 mM Na 2 HPO 4 , 10 mM glucose, pH 8.6) for 5 min. Midguts were dissected after the removal of peritrophic membranes and malpighian tubules. Freshly prepared midguts were kept in the dissecting buffer and used for the ex vivo assay within 2 h after dissection.
Ex vivo toxicity assay Cytotoxicity was assessed via a cell viability assay using the CellTiter96 ® AQ ueous kit (Promega Corporation, Madison, USA), which is based on the quantitative determination of the conversion of a tetrazolium compound to a formazan product that is directly proportional to the number of living cells. The assay was performed in a 96-well flat-bottomed microtitre plate containing 70 µl of the dissecting buffer with 5 isolated midguts. Three wells were used for each toxin in each experiment. After adding 10 µl of the toxin samples (3-6 µg) and 20 µl of the CellTiter96 solution, formation of the reduced formazan product in each well was simultaneously monitored at 490 nm by using a SpectraMax 250 microtitre plate reader (Molecular Devices Corporation, Sunnyvale, USA), and the background signal that measured at A 650 was subtracted. A 490 readings were recorded at intervals of 1 min for a period of 3 h at room temperature. Three independent experiments were carried out for each toxin sample.
Each reaction curve was analyzed by nonlinear regression using GraphPad PRISM version 2.0. Net toxic potency value (T net ) for each toxin was calculated by subtraction of the specific cell death factor with that of the buffer. A statistical analysis was carried out by using one-way analysis of variance (ANOVA) tests for comparing all the group means. The Tukey-type multiple comparison testing among pairs of group means (Zar, 1984) was used as post tests to determine which groups are statistically significantly different from other groups. Probabilities <0.05 were considered as being significant.
In vivo larvicidal activity assays A mosquito-larvicidal activity test was performed, as described previously, using 2-d old A. aegypti larvae (Sramala et al., 2000) . The assay was carried out with 1 ml of E. coli suspension (10 8 cells suspended in distilled water) in a 48-well mirotitre plate (11.3 mm well diameter), with 10 larvae per well and a total of 100 larvae for each E. coli clone. Mortality was recorded after a 24-h incubation.
Results and Discussion
The in vivo bioassays that are presented here (Fig. 1) clearly confirm our previous report (Angsuthanasombat et al., 1992) that E. coli cells expressing the 130-kDa Cry4B toxin were highly active (95.7 ± 1.8% mortality) against A. aegypti larvae, but not against C. quinquefasciatus larvae. The E. coli cells expressing the mutant-R158A, whose Arg-158 in helix 4 was mutated to alanine (Sramala et al., 2001) , or the lepidopteran-specific Cry1Aa toxin were relatively non-toxic to Aedes larvae (Fig. 1) . Examination of insect larval gut Fig. 1 . Mosquito-larvicidal activity of E. coli cells expressing one of Cry4B, its mutant (R158A), and Cry1Aa against A. aegypti larvae. E. coli cells containing the pUC12 vector were used as negative control cells. C. quinquefasciatus larvae were used as negative control larvae. Error bars indicate standard error of the means from three independent experiments. tissue following ingestion of the Bt toxins revealed that midgut epithelial cells are the primary action sites (Aronson et al., 1986) . In this context, the isolated midgut tissue of susceptible mosquito-larvae would, therefore, represent a good model system for directly investigating the underlying toxicity mechanism of the cloned Cry4B toxin.
As described previously, toxin activation of the cloned Cry4B protein that is expressed in the Bti strain IPS-78/11 can be simulated in vitro by solubilizing the protoxin inclusions in alkaline buffers and subsequently digesting with trypsin (Angsuthanasombat et al., 1991) . In this study, the Cry4B toxin, its non-toxic R158A mutant, and the Cry1Aa toxin (over-expressed in E. coli as inclusion bodies) were solubilized in a carbonate buffer, pH 10.0, and treated with trypsin. An SDS-PAGE analysis revealed that the 130-kDa Cry4B protoxin and the R-158 mutant were proteolytically processed to stable bands of ca. 47 and ca. 20 kDa (Fig. 2,  lanes 3-5) . These two fragments are produced by cleavage in the exposed loop linking helices 5 and 6 within the poreforming domain in addition to the removal of the C-terminal half of the Cry4B protein molecule; they remained associated under physiological conditions (Angsuthanasombat et al., 1993) . Unlike the Cry4B toxin, the 130-kDa Cry1Aa protoxin, upon trypsin digestion, showed a dominant proteaseresistant polypeptide of ca. 65 kDa (Fig. 2, lane 2) . Although there are no reports of interhelical proteolysis for the lepidopteran-specific Cry1 toxins, the 65-kDa activation products of Cry1Ac or Cry1C were able to lyse susceptible insect cell lines in vitro (Knowles and Ellar, 1987; Schwartz et al., 1991) .
Previous studies showed that the Cry4B toxin could bind only to the apical brush-border membranes of midgut cells of Anopheles gambiae mosquito larvae, but exhibited weak binding to gastric caecae and anterior gut regions (Ravoahangimalala and Charles, 1995) . In our study, Aedes larval epithelial cells were therefore prepared from isolated midguts for the assessment of Cry4B toxicity via a cell viability assay. After incubating the dissected midguts with the toxin samples, the number of viable epithelial cells was determined by a colorimetric method that monitors the quantity of water-soluble formazan products by photometric measurement at 490 nm (Cory et al., 1991) . Changes in A 490 were assumed to be directly proportional to the number of viable cells (Fig. 3) . It should be noted that a small decline of A 490 , which is due to the degradation of formazan that is possibly caused by oxidative agents from the dissected tissues, was observed in the assays. Therefore, the ex vivo data were corrected for the formazan degradation by the decay factor D, as shown in the following equation:
in which A 490 is the absorbance at 490 nm, t is the reaction time, k is the formazan generation constant, and D is the correction factor for formazan degradation. N t represents the number of cells at the time t. The decrease in the number of viable cells can be described by an exponential decay model as follows:
in which N o is the number of viable cells at t = 0, and T represents the specific cell death factor or toxic potency. Therefore, experimentally observed changes at A 490 can be expressed as a function of time. After substituting for Nt in equation 1, this gives, on integration:
where C is a constant of integration, which is approximately equal to A 490 max − A 490 min . The decay factor D for formazan degradation was experimentally determined to be 0.15 h −1 by fitting with decreasing A 490 values that were obtained after a 4-h incubation. Since the kN 0 parameter was used as a constant of 1 (an averaged experimental value of initial velocity of formazan development as No = Nt; t → 0), equation 3 may be simply written as follows:
The reaction curves (Fig. 3) revealed that the number of viable cells after a 1 h exposure to the 65-kDa trypsinactivated Cry4B toxin was significantly lower than that of the cells that were incubated with the protoxin or the trypsintreated products of Cry4B-R158A and Cry1Aa toxins. This result suggests that the toxic effect of the trypsin-treated Cry4B toxin on the Aedes midgut cells is comparatively higher than the protoxin and mutant, or trypsin-treated Cry1Aa toxin. These observations are almost consistent with the data that was obtained in bioassays as E. coli cells expressing the Cry4B-R158A mutant or the lepidopteranspecific Cry1Aa toxin was relatively non-toxic to Aedes larvae (Fig. 1) . Each reaction curve was analyzed for the potency parameter by nonlinear regression curve fitting (Fig. 4) and the net toxic potency (T net ) of the samples was compared. The analysis shows that the activated Cry4B toxin (30 µg ml −1 ) exhibits toxic potency, which is approximately 3.5 times (P < 0.01, Tukeys test) higher than the value for the 130-kDa protoxin (60 µg ml
−1
). The T net value (0.12 ± 0.06 h −1 ) that was observed for the Cry4B protoxin is conceivably due to the activity of the protoxin being activated by proteases that must occur in the isolated larval midguts. However, the trypsintreated products of both the non-bioactive Cry4B-R158A mutant and lepidopteran-active Cry1Aa toxin (30 µg ml , respectively (P value < 0.01). Consistent with the results of the in vivo activity that was mentioned earlier, an equivalent concentration (3 µg ml ). This indicates a very small population or the absence of Cry4B toxin-specific receptors on the midgut epithelial cell membranes of this non-susceptible insect.
In conclusion, we devised a microscale ex vivo cytotoxicity assay for assessing the insecticidal potency of the Cry4B mosquito-larvicidal proteins, and demonstrated that the trypsin-activated Cry4B toxin specifically exerted its cytolytic activity towards the isolated midguts from Aedes aegypti larvae. The availability of this ex vivo system will allow further investigation of the mechanism of action and the nature of the specific receptors on the Aedes midgut cell surface. ) and its mutant-R158A (30 µg ml −1
) that was treated with trypsin, the 130-kDa solubilized Cry4B protoxin (60 µg ml ) and the trypsin treated Cry1Aa toxin (30 µg ml −1 ), as determined by monitoring the absorbance at 490 nm. Reaction curves were analyzed to obtain the potency parameter by using a nonlinear regression curve fitting method with GraphPad PRISM version 2.0. ), of the Cry4B toxin and its mutant (R158A) treated with trypsin, the 130-kDa solubilized Cry4B protoxin, and the trypsin-treated Cry1Aa toxin on isolated A. aegypti larval midguts via the ex vivo cytotoxicity assay. The isolated C. quinquefasciatus larval midguts were used as negative control midgut cells for the activated Cry4B toxin. Error bars indicate standard error of the means from three independent experiments.
